Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma (PMR-MM-002)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
joost hegmans, Erasmus Medical Center
ClinicalTrials.gov Identifier:
NCT01241682
First received: June 1, 2010
Last updated: February 26, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2012
  Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)